Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Safety of Combined Standard Dose i.v. tPA (0.9mg/kg) followed by i.a. tPA vs. i.a. tPA alone in Acute Ischemic Stroke: is dose Reduction in Bridging Therapy Necessary?

Safety of Combined Standard Dose i.v. tPA (0.9mg/kg) followed by i.a. tPA vs. i.a. tPA alone in Acute Ischemic Stroke: is dose Reduction in Bridging Therapy Necessary?. The seventh joint meeting of the AANS/CNS section on cerebrovascular surgery and the American society of interventional and therapeutic neuroradiology. 2004.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.